Aktuella utlysningar, vecka 46, 2022
Grants Office tipsar aktuella utlysningar
Svenska och nordiska anslag
Stipendier för forskningsvistelser - STINT
STINT, Stiftelsen för internationalisering av högre utbildning och forskning, tillsammans med Japan Society for the Promotion of Science (JSPS) utlyser stipendier för forskningsvistelser i Japan. JSPS Postdoctoral Fellowship Program (Short-term) är öppet för forskning inom humaniora, naturvetenskap och samhällsvetenskap. Program erbjuder stipendier för 1 forskningsvistelse i Japan till PhD-studenter som är i slutfasen av sin utbildning, liksom nyligen examinerade doktorer under en period av 1 till 12 månader. Stipendier inkluderar resekostnader, en månatlig ersättning på 362 000 JPY för disputerad (PhD) och 200 000 JPY för icke-disputerad forskare, ett insättningsbidrag och försäkring.
Closing date: January 3, 2023
Stipendier för sommar forskningsvistelser - STINT
STINT, Stiftelsen för internationalisering av högre utbildning och forskning, tillsammans med Japan Society for the Promotion of Science (JSPS) utlyser JSPS Summer Program 2023 som vänder sig till masterstudenter, doktorander och nyblivna doktorer för att under två sommarmånader få en möjlighet att bekanta sig med Japan och japansk forskning. Stipendiater väljs med utgångspunkt i deras möjliga bidrag till ett förbättrat forskningssamarbete mellan Japan och Sverige.
Closing date: January 26, 2023
Swedish Childhood Cancer Fund
- Methodological studies and educational courses: enables researchers within the area of paediatric oncology to take up studies and educational courses abroad for up to three months.
- PhD courses: funding for organizing PhD courses within the field of pediatric oncology. The applicant should be active in the field of childhood cancer.
- Symposia: funding for for the organization of 1-2-day research symposia within the area of paedriatic oncology. The applicant should be active in the field of childhood cancer.
- Travel grants: funding for travel grants to researchers within the area of children oncology. Grants are intended to fully or partly finance travel costs to conferences and congresses within the area of children oncology.
- Guest lecturer: funding for invitation of prominent international guest lecturers. The lecture should be public and address a topic of large significance for children oncology.
Closing date: January 16, 2023
Excellence emerging investigator grant within endocrinology and metabolism, Nordic region - Novo Nordisk Foundation
With this call the Novo Nordisk Foundation (NNF) seeks to support and strengthen the development of young and promising research leaders, and to promote Nordic research at a high international level. The call is targeted starting group leaders with ambitious projects within endocrinology and metabolism that aim to understand the human organism and the mechanisms underlying health and disease at a basic and clinical level. Four grants are available for funding and NNF aims at awarding at least one of these grants to an active clinician researcher. Grants are worth up to DKK 10 million each over 5 years.
Closing date: January 17, 2023
Distinguished investigator grant within endocrinology and metabolism, Nordic region - Novo Nordisk Foundation
To promote Nordic research at the highest international level the Novo Nordisk Foundation (NNF) seeks to support outstanding professors with ambitious projects within endocrinology and metabolism to understand the human organism and the mechanisms underlying health and disease at a basic and clinical level. NNF will award up to two five-year grants worth up to DKK 10 million per grant.
Closing date: January 17, 2023
Ascending investigator grant within endocrinology and metabolism, Nordic region - Novo Nordisk Foundation
The purpose of this call is to stimulate the continued development of excellent research leaders, and promote Nordic research at a high international level. The Novo Nordisk Foundation (NNF) seeks to support the consolidation of accomplished associate professors with ambitious projects within endocrinology and metabolism to understand the human organism and the mechanisms underlying health and disease at a basic and clinical level. Three grants are available for funding. Grants are worth up to DKK 10 million.
Closing date: January 17, 2023
Anslag till forsknings- och utvecklingsprojekt - Afa Försäkring
Finansierar forskning inom arbetsmiljö som fokuserar på att förbättra arbetsmiljön och undersöka risk- och friskfaktorer i arbetet på kort och lång sikt. Forskningen förväntas förebygga och leda till färre arbetsskador såsom arbetssjukdomar och olycksfall. Vi finansierar forskning inom arbetsmiljö med fokus bland annat på: organisatorisk och social arbetsmiljö, kognitiv ergonomi, belastningsergonomi och arbetssjukdomar. Utlysningen riktar sig till forskare vid svenska universitet och högskolor, forskningsinstitut och universitetssjukhus.
Closing date: January 17, 2023.
Announcement of seed funding within the field of oral health for collaboration with National Dental Centre Singapore
The internationalisation advisory council is pleased to announce the availability of limited competitive funds for grant applications to strengthen collaborative interactions within oral health and innovations. The funds are to be used as “seed grants” aiming at starting or sustaining bilateral collaborations with Singapore within the field of oral health innovations and biotechnologies, in order to address emerging issues in global health. The funding can be used to facilitate writing of joint applications to major granting agencies or be used for joint training of research staff and students.
Closing date: December 9, 2022 (extended deadline)
Stiftelsen Clas Groschinskys Minnesfond
Delar ut forskningsanslag och verksamhetsbidrag till:
• Forskare inom medicin.
• Forskare inom social- och beteendevetenskap. För denna forskargrupp kan även stipendier tilldelas.
• Social verksamhet.
All information, ansökningsblanketter och villkor för anslag/stipendier finns från och med 20 november 2022 på stiftelsens hemsida
Ansökningshandlingar skall vara stiftelsen tillhanda senast 2023-01-31
Forskningsbidrag från Märta Lundqvists Stiftelse år 2022/2023
Stiftelsens övergripande syfte är att främja forskningen om den mänskliga hjärnan vid svenska universitet. Särskilt kommer patientrelaterad och kliniskt fokuserad forskning att prioriteras. Stiftelsen har även som målsättning att stimulera yngre forskare.
Forskningsprogrammet ska innehålla tydliga mål så att resultatet av erhållna medel kan utvärderas. Storleken på utdelningsbara medel i år uppgår till 2 7 40 000 kronor.
Vem kan söka anslag?
Utlysningen riktar sig till forskare vid svenska universitet med avlagd doktorsexamen (bevis i bilaga) inom tidsramen 5 år, dvs efter 1 januari 2018. Avräkning av tid kan ske för föräldraledighet och tid för eventuell klinisk tjänstgöring inom hälso- och sjukvården.
Stiftelsen har som policy att inte stödja ett och samma projekt i mer än 5 år. Dock kan undantag ske i särskilda fall.
Ansökan som kan skrivas på svenska eller engelska omfattar bl.a. uppgifter om projektledare, medelsförvaltare och sökt bidrag samt följande obligatoriska bilagor:
• Projektbeskrivning (forskningsprogram)
Projektbeskrivningen ska omfatta maximalt 5 A4-sidor exklusive referenser (12 punkters textstorlek). Projektbeskrivningen skickas in tillsammans med de övriga bilagorna i en för ansökan gemensamt sammanfogad pdf-fil.
- Sammanfattning av projektet (högst 250 ord)
- Syfte, hypotes och frågeställning
- Hittills uppnådda resultat (om sådana finns)
- Förväntade resultat i relation till projektets mål
- Hur länge projektet förväntas pågå
- Projektets vetenskapliga och praktiska betydelse
Utlysningen av programmet pågår från november 2022 med sista datum för inskickande av ansökan 12 januari, kl. 24.00, 2023.
Beredningsarbetet pågår under våren 2023 och beslut förväntas under maj månad.
Utbetalning för de bidrag som kan komma att beviljas sker till respektive lärosäte. Såväl vetenskaplig som ekonomisk redovisning för hur medlen använts ska inlämnas till Stiftelsen senast 2 år efter utbetalningsdatum.
Ansökan skickas till e-post: email@example.com
Lennart Kenne Minnesfonden har öppnat årets utlysning av stipendier för unga forskare som jobbar med strukturstudier av biomolekyler och naturprodukter.
Deadline för årets ansökningar är den 15:e december 2022.
Information om fonden och utlysningen
Research unit - European Society for Paediatric Endocrinology
The European Society for Paediatric Endocrinology, with support from Sandoz, invites applications for its research unit. This supports collaborative research in paediatric endocrinology.
Members of ESPE may apply. Each application must include at least one principal investigator and two co-investigators who are ESPE members. Non-ESPE members may participate as additional co-investigators. Applications that consist of investigators from at least three different countries are encouraged. The majority of the research should be performed at the investigators’ centre.
One large grant is available annually. The large grant is worth €100,000 for a period of two years. The large grant covers salary, materials and consumables, small items of equipment, collaborative visits and overheads.
Closing date: 15 September 2023
Research grants - Cure Parkinson’s Trust
The Cure Parkinson’s Trust invites applications for its research grants. These support laboratory or clinical research projects that have the potential to cure Parkinson’s disease. Applications must be for research that slows, stops or reverses underlying disease progression. Priority is given to research which has potential to translate into the clinic within five years.
Applications are invited world wide.
Closing date: 9 January 2023
National grant – Nordic and Baltic countries - Biocodex Microbiota Foundation
The Biocodex Microbiota Foundation invites applications for its national grant – Nordic and Baltic countries. This supports scientific research initiatives involving the human gut microbiota, dysbiosis and diseases.
Research must be carried out in an institution in Nordic-Baltic countries.
Grants are worth up to €40,000 each.
Closing date: 31 December 2022
Eppendorf award for young European investigators - Eppendorf AG
The Eppendorf AG, in partnership with the scientific journal Nature, invites entries for its award for young European investigators. This recognises contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.
European researchers, not older than 35 years, who hold a PhD or MD and who are performing biomedical research in Europe based on methods of molecular biology, including novel analytical concepts, may apply.
The award consists of €20,000 plus coverage of the prize winner’s work by Nature in print and online, an invitation to the prize ceremony and a visit to the Eppendorf SE in Hamburg, Germany.
Closing date: 15 January 2023
Research grant - Cystic Fibrosis Research Foundation
The Italian Cystic Fibrosis Research Foundation invites applications for its research grant. This supports research projects aiming to improve the health status of cystic fibrosis patients. Research projects dealing with either clinical studies or pre-clinical studies exploiting animal models of CF are strongly encouraged. Priority areas include:
•innovative therapies to correct defective CFTR or to compensate for its deficient function;
•identification and validation of new and appropriate in vivo and ex vivo assays to predict and monitor the potential efficacy of new therapies finalised to correct the CFTR defect;
•airway infection in CF – development of innovative diagnostic and antimicrobial strategies with special indication for the rapid and accurate diagnosis of infections and the treatment of difficult-to-treat microorganisms;
•inflammation in CF – innovative strategies to contain the inflammation-based pathology;
•clinical applications and epidemiological studies.
If PIs and multicentre project co-ordinators live and work in another European country, at least one partner in the project must be resident and work in Italy.
Closing date: 15 February 2023
Federal Funding agencies
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed): NIH
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate basic technology-focused research to develop next-generation human cell-derived microphysiological systems (MPS) and related assays with improved fidelity to complex human brain, spinal cord, and/or sensory end organ circuit physiology, which will ultimately facilitate analysis of higher order functional deficits relevant to complex nervous system diseases. These models will have a multi-lineage, complex architecture representing the normal characteristics and functions of the relevant nervous system structure (e.g., sensory input systems, brain or spinal integrative systems, motor output systems) and will substantially exceed the state of the art in cellular maturation and integration, allowing reproducible measurement of human-relevant circuit-level activity under physiological conditions over a long period.
Deadline: February 16, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-23-047
Investigating the Effects of Addictive Substances on Brain Developmental Trajectories Using Innovative Scalable Methods for Quantification of Cell Identity, Lineage and Connectivity (R01 - Clinical Trial Not Allowed): NIH
This Funding Opportunity Announcement (FOA) will support projects that investigate the effects of addictive substances on developmental trajectories of molecularly-defined central nervous system (CNS) cells and circuits. Emphasis is on carrying out systematic and highly granular quantitative characterizations of the impact of in utero and/or postnatal substance exposure on the numbers, spatial distribution and connectivity of molecularly-defined cells, across whole brains or within distributed circuits of clinical relevance. The ultimate goals of the program are to identify critical developmental windows and cellular mechanisms mediating the protracted developmental impact of addictive substances, and to inform clinical practice, by complementing the data from human longitudinal neuroimaging studies such as the HEALthy Brain and Child Development (HBCD) Study and the Adolescent Brain Cognative Development (ABCD) Study.
Deadline: February 02, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-DA-23-036
Notice of Special Interest (NOSI): Advancing Research in Lipoprotein(a) and Cardiovascular Disease (R01 Clinical Trials Allowed) and (R01 No Clinical Trials Allowed): NIH
The National Heart, Lung, and Blood Institute invites applications for its Notice of Special Interest (NOSI): Advancing Research in Lipoprotein(a) and Cardiovascular Disease (R01 Clinical Trials Allowed) and (R01 No Clinical Trials Allowed) funding opportunity. This supports research on lipoprotein(a) and its role in cardiovascular disease (CVD). Multidisciplinary collaborations to conduct basic, preclinical, and mechanistic clinical studies on Lp(a) and CVD are encouraged. Research areas of interest include, but are not limited to the following:
- Study the biosynthesis of apo(a), endogenous Lp(a) particle assembly, secretion, and clearance
- Elucidate the relationship between Lp(a) structure and function
- Investigate the route of Lp(a) catabolism in both physiological and altered conditions and identify relevant receptors
- Develop new model systems such as in vitro cell lines and in vivo animal models that are suited for Lp(a) research
- Examine the mechanism(s) of Lp(a) in CVD development e.g., Lp(a) may contribute to oxidation, inflammation, fibrinolysis, and atherogenesis
- Identify new targets and novel mechanisms of Lp(a)-lowering for the development of therapeutic agents
- Understand the mechanistic links between apo(a) isoforms and SNPs and risk for CVD
- Evaluate risk and therapy thresholds of Lp(a) and genetic contribution to differences in Lp(a) levels in different racial/ethnic groups
- Determine the clinical utility of Lp(a) to predict risk in diverse population-based studies using optimal laboratory assays
- Explore the potential of improving Lp(a) standardization by the harmonization of different Lp(a) assays
Deadline: This notice applies to due dates on or after February 5, 2023 and subsequent receipt dates through January 7, 2026.
Funding Opportunity Announcement (FOA): NOT-HL-22-052
The Zenith Fellows Award Program, Alzheimer’s Association, US
The Alzheimer’s Association, with sponsorship from the Zenith Society, invites letters of intent for the Zenith fellows award. This enables established independent investigators to work on the advancement of Alzheimer’s and other dementias research. Research must be on the cutting edge of basic biomedical research and therefore may challenge the prevailing orthodoxy. It should address fundamental problems related to early detection, aetiology, pathogenesis, treatment and prevention of Alzheimer’s and other dementias.
Eligibility: Applicants must hold an academic appointment, have received major, peer-reviewed, external grant support and have a good publication record. They must have already contributed significantly to the field of Alzheimer’s or have the clear likelihood of making significant contributions. Previous recipients are not eligible. Scientists from underrepresented groups are encouraged to apply.
Budget: Up to three awards may be granted. Each award is worth up to USD 450,000 for up to three years. Requests in any given year may not exceed USD 250,000 and indirect costs may not exceed 10%.
Deadline: LOI – 20th January, 2023. Full application – 19th April 2023.
Grant programmes, Foundation for Angelman Syndrome Therapeutics, US
Impact Grant Programme. The Foundation for Angelman Syndrome Therapeutics invites applications for its impact grant programme. This supports large therapeutic translational research platform projects from pre-clinical to IND-enabling stage. The award is open to novel approaches or repurposing approved or other clinically safe therapies evaluated in other disease indications that could advance Angelman syndrome research. Eligibility: Open to all. Budget: Grants are worth up to USD 1 million per year. Each award will also include a USD 3,000 travel stipend to allow for the PI and one trainee to travel to the annual FAST scientific symposium. FAST allows up to 10% indirect cost rate to the budget’s modified total direct costs to be included in the total cost of the project.
New investigator award. The Foundation for Angelman Syndrome Therapeutics invites applications for its new investigator award. This supports a new scientist that is looking to start a significant research programme focusing on translational research in Angelman syndrome, or on technologies specifically relevant to advancing Angelman Syndrome treatment modalities. Eligibility: Applicants should be within their first five years of an academic position at an institution or university. They should have either accepted an offer or already been appointed to an academic position and have a history of research in a relevant field. Budget: Grants are worth USD 250,000 per year for two years. A third year extension worth USD 125,000 may be requested. FAST allows up to 10% indirect cost rate to the budget’s modified total direct costs to be included in the total cost of the project.
Postdoctoral fellowship programme. The Foundation for Angelman Syndrome Therapeutics invites applications for its postdoctoral fellowship programme. This aims to encourage therapeutic translational research agendas focusing on potential treatments, research, or biomarker and outcome measure development that will greatly enhance the progress of these platforms toward human benefit for Angelman syndrome. Preference will be given to research projects that have a translational application to human benefit. Eligibility: Research clinicians must devote full-time to their proposed research training and must restrict clinical duties within their full-time research training experience to activities that are directly related to the research training experience. Budget: Grants consist of a yearly stipend worth USD 46,000, a travel allowance of USD 1,500 and research expenses worth USD 3,000. Fellowships are awarded for the period of one year and may be renewed for a second year, based on satisfactory progress. FAST does not allow indirect costs for this grant.
Deadline: You can apply for these opportunities at any time. All grant applications have a rolling deadline.
Cross-Species Studies of ASD, Simons Foundation, US
The Simons Foundation invites applications for its cross-species studies of ASD funding opportunity. This supports multi-disciplinary teams of PIs with expertise in both human and animal research to perform coordinated cross-species studies to advance our understanding of ASD-relevant behaviors and their underlying neurobiological mechanisms, with the potential for developing novel biomarkers or interventions. This also supports research on ASD-relevant behaviours and their underlying neurobiological mechanisms conducted in parallel across human and non-human animals. Beyond measuring behaviors in parallel across species, special emphasis is placed on furthering our understanding of the underlying neurobiological mechanisms with an eye towards developing novel biomarkers or interventions.
Eligibility: PIs who do not have substantial expertise with ASD participants should include a close collaborator with such expertise on their grant application.
Budget: Grants are worth up to USD 400,000 for up to three years, inclusive of 20% indirect costs.
Deadline: Full Application: 15th June, 2023.
Bridge to success grant for early-career investigators, American Academy of Sleep Medicine, US
The American Academy of Sleep Medicine invites submissions for its bridge to success grant for early-career investigators. This provides bridge funding to early-career sleep and circadian scientists who have unsuccessfully applied for a career development award, such as a K-award grant from the National Institutes of Health, a career development award from the U.S. Department of Veterans Affairs, or an equivalent career development grant from another federal or non-federal entity, to assist investigators to stay in the sleep field.
Eligibility: Individuals with the following education and training are eligible to apply: sleep scientists (MD, DO, DDS, DMD, DNP, DNSc, PharmD, PhD, or equivalent) who have applied for a multi-year career development grant from the NIH, VA or another granting body in the field of sleep or circadian science within the past two years that was scored in the peer-review process but fell below (or is likely to fall below) the funding agency’s pay line. Individuals who have received independent research funding of more than $150,000 are not eligible to apply. This does not apply to post-doctoral/ fellowship level training grants primarily covering the applicant’s salary (e.g. NRSAs).
Budget: The grant provides funds for one year and can be for up to USD 100,000 per grant (includes direct and indirect costs). There are no restrictions on the distribution of expenses, however, indirect costs are capped at 8%.
Deadline: Full application – 9th January 2023.